Volume is the basic fuel of the market since stocks move up or down in price only when shares are trading hands. 0 analysts call it Underweight, while 0 think it is Overweight. The share price has moved forward from its 20 days moving average, trading at a distance of 20.62% and stays 22.13% away from its 50 days moving average. As traders, we are more interested to take part in strong moves and don't join moves that show weakness - or we may even watch for an entry in the opposite direction of a weak move. The shares price has positioned 5.26% up over the past quarter while it has directed 3.45% toward a rising position throughout past six months. The company's beta value is at 0.45. The Volatility was noted at 1.01% in recent month and it observed Weekly Volatility of 1.04%. Recently, investment analysts covering the stock have updated the mean rating to 2. On a Monthly basis the stock is 16.20%.
ATR value of the company was 0.09 and Relative Strength Index (RSI) was 69.54. It has a Return on Investment (ROI) of 1.20% and a gross margin of 30.00%. The analysts estimated EPS for the higher end at -0.22 and lower end at -0.27 while the year ago reported earnings per share was -0.29.
Shares of Express, Inc. This is not a recommendation to buy or sell OncoSec Medical Incorporated (NASDAQ:ONCS). During last 3 month period, 26.54% of total institutional ownership has changed in the company shares. A stock that maintains a relatively stable price has low volatility.
Tightening the gaze, stock performance for the last 5 trading days is 3.81%.
OncoSec Medical Incorporated (NASDAQ:ONCS)'s stock had its "buy" rating reissued by equities research analysts at Maxim Group in a research report issued to clients and investors on Tuesday.
OncoSec Medical Incorporated (NASDAQ:ONCS) is struggling to gain traction with investors, as evidenced by its 4.22 million shares volume. OncoSec Medical has an average rating of Buy and a consensus price target of $5.33. After a recent check, it is observed that the insiders for the firm now own 3.57% shares.
The industry and sector ratio of Price to Cash Flow ticked at 7.64 and 9.99 respectively.
OncoSec Medical Incorporated (NASDAQ:ONCS), stock is trading $2.08 above the 52-week high and has displayed a high EPS growth of -6.50% in last 5 years. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. In the most recent financial results released by OncoSec Medical Incorporated, for the quarter ending on 2017-04-30, the company posted EPS of -0.22.